127 related articles for article (PubMed ID: 38615920)
1. CaMK4: Structure, physiological functions, and therapeutic potential.
Xu H; Yong L; Gao X; Chen Y; Wang Y; Wang F; Hou X
Biochem Pharmacol; 2024 Jun; 224():116204. PubMed ID: 38615920
[TBL] [Abstract][Full Text] [Related]
2. CaMK4 is a downstream effector of the α
Zheng Z; Wang X; Wang Y; King JAC; Xie P; Wu S
Am J Physiol Cell Physiol; 2021 Dec; 321(6):C964-C977. PubMed ID: 34586897
[TBL] [Abstract][Full Text] [Related]
3. The role of CaMK4 in immune responses.
Koga T; Kawakami A
Mod Rheumatol; 2018 Mar; 28(2):211-214. PubMed ID: 29252071
[TBL] [Abstract][Full Text] [Related]
4. CaMK4 promotes abortion-related Th17 cell imbalance by activating AKT/mTOR signaling pathway.
Chang S; Yin T; He F; Ding J; Shang Y; Yang J
Am J Reprod Immunol; 2020 Dec; 84(6):e13315. PubMed ID: 32738170
[TBL] [Abstract][Full Text] [Related]
5. Calcium/Calmodulin Kinase IV Controls the Function of Both T Cells and Kidney Resident Cells.
Ferretti AP; Bhargava R; Dahan S; Tsokos MG; Tsokos GC
Front Immunol; 2018; 9():2113. PubMed ID: 30333818
[TBL] [Abstract][Full Text] [Related]
6. Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling.
Chen L; Tang YL; Liu ZH; Pan Y; Jiao RQ; Kong LD
Eur J Pharmacol; 2021 Dec; 913():174616. PubMed ID: 34780752
[TBL] [Abstract][Full Text] [Related]
7. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
[TBL] [Abstract][Full Text] [Related]
8. The CaMK4/CREB/IRS-2 cascade stimulates proliferation and inhibits apoptosis of β-cells.
Liu B; Barbosa-Sampaio H; Jones PM; Persaud SJ; Muller DS
PLoS One; 2012; 7(9):e45711. PubMed ID: 23049845
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.
Kono M; Maeda K; Stocton-Gavanescu I; Pan W; Umeda M; Katsuyama E; Burbano C; Orite SYK; Vukelic M; Tsokos MG; Yoshida N; Tsokos GC
JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217348
[TBL] [Abstract][Full Text] [Related]
10. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.
Maeda K; Otomo K; Yoshida N; Abu-Asab MS; Ichinose K; Nishino T; Kono M; Ferretti A; Bhargava R; Maruyama S; Bickerton S; Fahmy TM; Tsokos MG; Tsokos GC
J Clin Invest; 2018 Aug; 128(8):3445-3459. PubMed ID: 29985166
[TBL] [Abstract][Full Text] [Related]
11. Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies.
Hoda N; Naz H; Jameel E; Shandilya A; Dey S; Hassan MI; Ahmad F; Jayaram B
J Biomol Struct Dyn; 2016; 34(3):572-84. PubMed ID: 25929263
[TBL] [Abstract][Full Text] [Related]
12. MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4).
Li Z; Lu J; Zeng G; Pang J; Zheng X; Feng J; Zhang J
Cell Death Dis; 2019 Oct; 10(11):789. PubMed ID: 31624237
[TBL] [Abstract][Full Text] [Related]
13. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice.
Lee HY; Gattu AK; Camporez JP; Kanda S; Guigni B; Kahn M; Zhang D; Galbo T; Birkenfeld AL; Jornayvaz FR; Jurczak MJ; Choi CS; Yan Z; Williams RS; Shulman GI; Samuel VT
Diabetologia; 2014 Jun; 57(6):1232-41. PubMed ID: 24718953
[TBL] [Abstract][Full Text] [Related]
15. CaMK4-dependent phosphorylation of Akt/mTOR underlies Th17 excessive activation in experimental autoimmune prostatitis.
Zhan CS; Chen J; Chen J; Zhang LG; Liu Y; Du HX; Wang H; Zheng MJ; Yu ZQ; Chen XG; Zhang L; Liang CZ
FASEB J; 2020 Oct; 34(10):14006-14023. PubMed ID: 32862457
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis.
Koga T; Umeda M; Yoshida N; Satyam A; Jha M; Scherlinger M; Bhargava R; Tsokos MG; Sato T; Furukawa K; Endo Y; Fukui S; Iwamoto N; Abiru N; Okita M; Ito M; Kawakami A; Tsokos GC
Rheumatology (Oxford); 2023 Feb; 62(2):861-871. PubMed ID: 35781320
[TBL] [Abstract][Full Text] [Related]
17. CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation.
Zhang Y; Daniel EA; Metcalf J; Dai Y; Reif GA; Wallace DP
J Mol Cell Biol; 2022 Sep; 14(7):. PubMed ID: 36002021
[TBL] [Abstract][Full Text] [Related]
18. Understanding the pathogenic significance of altered calcium-calmodulin signaling in T cells in autoimmune diseases.
Koga T
Clin Immunol; 2024 May; 262():110177. PubMed ID: 38460894
[TBL] [Abstract][Full Text] [Related]
19. Calcium/calmodulin dependent protein kinase IV in trophoblast cells under insulin resistance: functional and metabolomic analyses.
Li L; Li L; Shao Y; Du R; Li L; Shi X; Bai Y
Mol Med; 2023 Jun; 29(1):82. PubMed ID: 37386367
[TBL] [Abstract][Full Text] [Related]
20. CaMK4 Promotes Acute Lung Injury Through NLRP3 Inflammasome Activation in Type II Alveolar Epithelial Cell.
Zhang T; Li M; Zhao S; Zhou M; Liao H; Wu H; Mo X; Wang H; Guo C; Zhang H; Yang N; Huang Y
Front Immunol; 2022; 13():890710. PubMed ID: 35734175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
